These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 15122798

  • 1. Limited long-term naive CD4+ T cell reconstitution in patients experiencing viral load rebounds during HAART.
    Choremi-Papadopoulou H, Tsalimalma K, Dafni U, Dimitracopoulou A, Kordossis T.
    J Med Virol; 2004 Jun; 73(2):235-43. PubMed ID: 15122798
    [Abstract] [Full Text] [Related]

  • 2. Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children.
    Paul ME, Shearer WT, Kozinetz CA, Lewis DE.
    J Allergy Clin Immunol; 2001 Aug; 108(2):258-64. PubMed ID: 11496243
    [Abstract] [Full Text] [Related]

  • 3. Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.
    Beran O, Holub M, Spála J, Kalanin J, Stanková M.
    Acta Virol; 2003 Aug; 47(2):121-4. PubMed ID: 14524479
    [Abstract] [Full Text] [Related]

  • 4. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI.
    Cytometry B Clin Cytom; 2007 Jan 15; 72(1):14-21. PubMed ID: 17041945
    [Abstract] [Full Text] [Related]

  • 5. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
    Kolber MA.
    AIDS; 2008 Oct 01; 22(15):1937-41. PubMed ID: 18784457
    [Abstract] [Full Text] [Related]

  • 6. Changes in T-cell subpopulations during four years of suppression of HIV-1 replication in patients with advanced disease.
    Lepej SZ, Begovac J, Vince A.
    FEMS Immunol Med Microbiol; 2006 Apr 01; 46(3):351-9. PubMed ID: 16553807
    [Abstract] [Full Text] [Related]

  • 7. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
    Stone SF, Price P, French MA.
    HIV Med; 2005 Jul 01; 6(4):278-83. PubMed ID: 16011533
    [Abstract] [Full Text] [Related]

  • 8. Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.
    Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.
    Scand J Immunol; 2008 Dec 01; 68(6):652-60. PubMed ID: 19055701
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H, Zheng YH, Shen Z, Liu M, Liu C, He Y, Chen J, Ou QY, Huang ZL.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 13; 87(42):2973-6. PubMed ID: 18261327
    [Abstract] [Full Text] [Related]

  • 10. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients.
    Almeida M, Cordero M, Almeida J, Orfao A.
    Cytometry B Clin Cytom; 2007 Jan 15; 72(1):22-33. PubMed ID: 17051525
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcomes and immune reconstitution in 103 advanced AIDS patients undergoing 12-month highly active antiretroviral therapy.
    Dai Y, Qiu ZF, Li TS, Han Y, Zuo LY, Xie J, Ma XJ, Liu ZY, Wang AX.
    Chin Med J (Engl); 2006 Oct 20; 119(20):1677-82. PubMed ID: 17097013
    [Abstract] [Full Text] [Related]

  • 12. CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation.
    Benito JM, Lopez M, Lozano S, Ballesteros C, Capa L, Martinez P, Gonzalez-Lahoz J, Soriano V.
    J Infect Dis; 2005 Dec 15; 192(12):2142-6. PubMed ID: 16288380
    [Abstract] [Full Text] [Related]

  • 13. Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.
    Papasavvas E, Sandberg JK, Rutstein R, Moore EC, Mackiewicz A, Thiel B, Pistilli M, June RR, Jordan KA, Gross R, Maino VC, Nixon DF, Montaner LJ.
    J Infect Dis; 2003 Sep 15; 188(6):873-82. PubMed ID: 12964119
    [Abstract] [Full Text] [Related]

  • 14. [Dynamics of T lymphocyte subsets in HAART treated AIDS patients with successful suppression of HIV replication and different CD4 + T cell restoration].
    Qiu ZF, Li TS, Ruan GR, Han Y, Xie J, Zuo LY, Li YL, Wang AX.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun 15; 28(3):386-90. PubMed ID: 16900640
    [Abstract] [Full Text] [Related]

  • 15. Markers of lymphocyte homing distinguish CD4 T cell subsets that turn over in response to HIV-1 infection in humans.
    Hengel RL, Jones BM, Kennedy MS, Hubbard MR, McDougal JS.
    J Immunol; 1999 Sep 15; 163(6):3539-48. PubMed ID: 10477629
    [Abstract] [Full Text] [Related]

  • 16. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM, Schapiro JM, Winters MA, Merigan TC.
    AIDS Res Hum Retroviruses; 1998 May 01; 14(7):561-9. PubMed ID: 9591710
    [Abstract] [Full Text] [Related]

  • 17. Humoral response to hepatitis B vaccination and its relationship with T CD45RA+ (naïve) and CD45RO+ (memory) subsets in HIV-1-infected subjects.
    Veiga AP, Casseb J, Duarte AJ.
    Vaccine; 2006 Nov 30; 24(49-50):7124-8. PubMed ID: 16884833
    [Abstract] [Full Text] [Related]

  • 18. Immunologic features of HIV-1-infected women on HAART at delivery.
    Ono E, Dos Santos AM, Machado DM, Succi RC, Amed AM, Salomão R, Kallás EG, de Moraes-Pinto MI.
    Cytometry B Clin Cytom; 2008 Jul 30; 74(4):236-43. PubMed ID: 18393385
    [Abstract] [Full Text] [Related]

  • 19. T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART.
    Marziali M, De Santis W, Carello R, Leti W, Esposito A, Isgrò A, Fimiani C, Sirianni MC, Mezzaroma I, Aiuti F.
    AIDS; 2006 Oct 24; 20(16):2033-41. PubMed ID: 17053349
    [Abstract] [Full Text] [Related]

  • 20. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T, Brouwer M, Girma M, Fontanet AL, Miedema F, Hamann D, Rinke de Wit TF.
    Clin Immunol; 2001 Feb 24; 98(2):212-9. PubMed ID: 11161977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.